222 related articles for article (PubMed ID: 16557202)
21. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE
Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
[TBL] [Abstract][Full Text] [Related]
22. Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care.
Israel O; Kuten A
J Nucl Med; 2007 Jan; 48 Suppl 1():28S-35S. PubMed ID: 17204718
[TBL] [Abstract][Full Text] [Related]
23. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
[TBL] [Abstract][Full Text] [Related]
24. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
25. PET and PET/CT in pediatric oncology.
Jadvar H; Connolly LP; Fahey FH; Shulkin BL
Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
[TBL] [Abstract][Full Text] [Related]
26. Tumor biology-guided radiotherapy treatment planning: gross tumor volume versus functional tumor volume.
Guha C; Alfieri A; Blaufox MD; Kalnicki S
Semin Nucl Med; 2008 Mar; 38(2):105-13. PubMed ID: 18243845
[TBL] [Abstract][Full Text] [Related]
27. Mass effect of injected dose in small rodent imaging by SPECT and PET.
Kung MP; Kung HF
Nucl Med Biol; 2005 Oct; 32(7):673-8. PubMed ID: 16243641
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia imaging markers and applications for radiation treatment planning.
Lin A; Hahn SM
Semin Nucl Med; 2012 Sep; 42(5):343-52. PubMed ID: 22840599
[TBL] [Abstract][Full Text] [Related]
29. Imaging of tumor physiology: impacts on clinical radiation oncology.
Astner ST; Shi K; Vaupel P; Molls M
Exp Oncol; 2010 Sep; 32(3):149-52. PubMed ID: 21403609
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of and diagnostic methods for tumoral hypoxia].
Maslennikova AV; Orlova AG; Prianikova TI; Kostenikov NA; Vinogradova IuN; Denisenko AN
Vopr Onkol; 2011; 57(4):413-20. PubMed ID: 22191227
[No Abstract] [Full Text] [Related]
31. [Positron emission tomography (PET) and PET/CT for guiding therapy in oncology].
Haug AR; Bartenstein P
Dtsch Med Wochenschr; 2011 Mar; 136(10):468-72. PubMed ID: 21365523
[No Abstract] [Full Text] [Related]
32. Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications.
Gallez B; Baudelet C; Jordan BF
NMR Biomed; 2004 Aug; 17(5):240-62. PubMed ID: 15366026
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of SPECT radiopharmaceuticals for imaging hypoxic tissues.
Wiebe LI; Stypinski D
Q J Nucl Med; 1996 Sep; 40(3):270-84. PubMed ID: 8961804
[TBL] [Abstract][Full Text] [Related]
34. PET imaging of hypoxia.
Lewis JS; Welch MJ
Q J Nucl Med; 2001 Jun; 45(2):183-8. PubMed ID: 11476169
[TBL] [Abstract][Full Text] [Related]
35. Small-animal PET: a promising, non-invasive tool in pre-clinical research.
Schnöckel U; Hermann S; Stegger L; Law M; Kuhlmann M; Schober O; Schäfers K; Schäfers M
Eur J Pharm Biopharm; 2010 Jan; 74(1):50-4. PubMed ID: 19482080
[TBL] [Abstract][Full Text] [Related]
36. Tumor oxygenation status as a prognostic marker.
Menon C; Fraker DL
Cancer Lett; 2005 Apr; 221(2):225-35. PubMed ID: 15808408
[TBL] [Abstract][Full Text] [Related]
37. Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles.
Peeters SG; Zegers CM; Yaromina A; Van Elmpt W; Dubois L; Lambin P
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):39-57. PubMed ID: 25517080
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia PET/CT imaging: implications for radiation oncology.
Arabi M; Piert M
Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):500-9. PubMed ID: 20927017
[TBL] [Abstract][Full Text] [Related]
39. Quantitative small animal PET.
Shoghi KI
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):365-73. PubMed ID: 19834445
[TBL] [Abstract][Full Text] [Related]
40. Review of positron emission tomography tracers for imaging of tumor hypoxia.
Imam SK
Cancer Biother Radiopharm; 2010 Jun; 25(3):365-74. PubMed ID: 20578843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
